The solute carrier family 2 facilitated glucose transporter member 1 (SLC2A1), and the solute carrier family 25 members (SLC25A6) transcripts and proteins were up-regulated in glioma versus normal brain tissues (Figure 9A,B). This evidence concerns the gene SLC25A6 and central nervous system cancer.